Financhill
Back

P3 Health Partners Quote, Financials, Valuation and Earnings

P3 Health Partners Price Quote

$0.21
0.00 (-2.33%)
(Updated: November 23, 2024 at 5:49 AM ET)

P3 Health Partners Key Stats

Sell
37
P3 Health Partners (PIII) is a Sell

Day range:
$0.20 - $0.22
52-week range:
$0.19 - $1.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.03
P/B ratio:
0.29%

Volume:
535.2K
Avg. volume:
891.5K
1-year change:
-81.32%
Market cap:
$34.7M
Revenue:
$1.3B
EPS:
$-0.86

How Much Does P3 Health Partners Make?

Is P3 Health Partners Growing As A Company?

  • What Is P3 Health Partners's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.26%
  • What Is P3 Health Partners's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

P3 Health Partners Stock Price Performance

What Is P3 Health Partners 52-Week High & Low?

P3 Health Partners Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy P3 Health Partners?

Is P3 Health Partners Cash Flow Positive?

  • What Is PIII Cash Flow From Operations?
    Cash flow from operations (TTM) is -$68.8M
  • What Is P3 Health Partners’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $64.2M
  • What Is P3 Health Partners’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $15.2M

P3 Health Partners Return On Invested Capital

  • Is Management Doing A Good Job?
    PIII return on invested capital is -20.12%
  • What Is P3 Health Partners Return On Assets?
    ROA measures how assets are converting to revenues and is -11.83%
  • What Is PIII Return On Equity?
    ROE is a measure of profitability and is -26.35%

P3 Health Partners Earnings Date & Stock Price

P3 Health Partners Competitors

  • Who Are P3 Health Partners's Competitors?
    Below is a list of companies who compete with P3 Health Partners or are related in some way:
    • American Shared Hospital Services (AMS)
    • Astrana Health Inc (ASTH)
    • Biote Corp (BTMD)
    • Cryo-Cell International Inc (CCEL)
    • Omnicell Inc (OMCL)

P3 Health Partners Dividend Yield

P3 Health Partners Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 25.58% 1.14%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 0.63
Upside from Last Price: 193.43%

Major Shareholders

  • How many PIII shares are owned by institutional investors?
    38.8M PIII shares are owned by institutional investors
  • How many PIII shares are owned by insiders?
    6.6M PIII shares are owned by insiders